Good news for the UFC’s newly created women’s featherweight division, as Cris “Cyborg” has been cleared of her potential doping violation after testing positive for Spironolactone in December 2016. USADA have have granted Cyborg a retroactive therapeutic use exemption, after investigating the failed urine test in December. Cyborg informed USADA that the Spironolactone was in her system from medication prescribed by her physician to treat an ongoing endocrine disorder. Cyborg was granted an exemption after USADA officials found “the athlete had an unequivocally diagnosed chronic medical condition for which the use of Spironolactone is the appropriate standard of care”.
Cyborg‘s provisional suspension has been lifted with immediate effect, and may return to competition as soon as a matchup can be booked. She has already expressed interest in fighting at UFC 212 in Brazil, headlined by the men’s featherweight championship unification bout between Jose Aldo and Max Holloway. Newly crowned UFC women’s featherweight champion Germaine de Randamie is at the top of Cyborg’s hit list, but this seems unlikely to happen anytime soon due to de Randamie requiring hand surgery. Invicta FC interim featherweight champion Megan Anderson has expressed interest in fighting in the UFC, and seems a logical matchup for Cyborg.
Regardless of the matchup, MMA fans worldwide will be excited for the most dominant woman in combat sports to return to the cage and show off her skills again.